ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Exemestane on Bone Strength (MAP3BSS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01144468
Recruitment Status : Active, not recruiting
First Posted : June 15, 2010
Last Update Posted : May 16, 2016
Sponsor:
Collaborator:
Canadian Breast Cancer Research Alliance
Information provided by (Responsible Party):
University Health Network, Toronto

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 2017
  Estimated Study Completion Date : June 2019

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 24, 2017  
Publications of Results:
Other Publications: